Weight Management

GLP-1 Weight Loss

100% Online — No Office Visit Required

GLP-1 receptor agonists represent a revolution in medical weight loss. OakMD offers provider-reviewed programs featuring semaglutide and tirzepatide for eligible adults.

Clinically proven weight loss medications
Provider-reviewed eligibility assessment
Personalized dosing protocol
Ongoing monitoring and support

What Is GLP-1 Weight Loss?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of injectable medications that mimic the GLP-1 hormone naturally produced in the gut. They slow gastric emptying, reduce appetite, improve blood sugar regulation, and promote significant weight loss in eligible adults.

What It May Help With

GLP-1 medications are used for chronic weight management in adults who meet eligibility criteria, which may include:

  • BMI ≥30 (obesity)
  • BMI ≥27 with a weight-related condition (e.g., hypertension, type 2 diabetes)
  • History of failed lifestyle interventions
  • Metabolic syndrome or insulin resistance

Who May Be a Candidate

Candidates for GLP-1 medications must meet clinical eligibility criteria. Your OakMD provider will review your BMI, health history, and goals to determine whether a GLP-1 program is appropriate.

How OakMD Works

OakMD is a telemedicine platform connecting eligible adults with licensed providers. If you're interested in GLP-1 Weight Loss, the process begins with a brief online intake form. A licensed provider will review your health history, symptoms, and goals — and determine if treatment is appropriate for you.

If you are a candidate, your provider will create a personalized treatment plan and guide you through next steps. There are no in-person visits required.

Frequently Asked Questions

Common Questions

How much weight will I lose on GLP-1?

Clinical trials have shown average weight loss of 10–22% of body weight depending on the medication and individual response. Results vary significantly.

Are GLP-1 medications injected?

Most GLP-1 medications (including semaglutide and tirzepatide) are administered via weekly subcutaneous injection. They are self-administered at home.

Ready to Get Started?

Complete a brief online intake. A licensed provider will review your information and determine if treatment is appropriate for you.

Medical Disclaimer: The information on this page is provided for educational purposes only and does not constitute medical advice. OakMD is a telemedicine platform. All treatments are prescription-based, subject to provider review, and may not be appropriate for all individuals. A licensed provider will evaluate your medical history and determine eligibility. Consult a qualified healthcare professional before starting any new treatment.